Comparison of T- and Z-score in identifying risk factors of osteoporosis in inflammatory bowel disease patients

Journal of Musculoskeletal Neuronal Interactions

Volumn 8, Issue 1, 2008, Pages 79-84

  Tsironi, Eftychia ^a,d   Hadjidakis, D ^a   Mallas, E ^b   Tzathas, C ^a   Karamanolis, D G ^c   Ladas, S D ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c Gastroenteroklogy Department   (Greece)

^d Tzancio Hospital ^*  (Greece)

Author keywords

Bone density; Crohn's disease; Inflammatory bowel disease; Osteoporosis; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; CIPROFLOXACIN; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MESALAZINE; METRONIDAZOLE; PREDNISOLONE;

ADULT; AGE; AGED; ANALYTICAL PARAMETERS; BONE DENSITY; CONFERENCE PAPER; CONTROLLED STUDY; CROHN DISEASE; DRUG USE; DUAL ENERGY X RAY ABSORPTIOMETRY; ENTERITIS; FEMALE; FEMUR NECK; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PREDICTION; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; ULCERATIVE COLITIS;

ABSORPTIOMETRY, PHOTON; ADULT; BONE DENSITY; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FEMUR NECK; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; OSTEOPOROSIS; RISK FACTORS;

EID: 51749111167     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN. The incidence of fractures among patients with IBD: a population-based study. Ann Intern Med 2000; 133:795-9.
2. Vestergaard P, Krogh K, Rejnmark L, Laurberg S, Mosekilde L. Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut 2000;46:176-81.
3. Klaus J, Armbrecht G, Steinkamp M, Bruckel J, Rieber A, Adler G, Reinshagen M, Felsenberg D, von Tirpitz C. High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease. Gut 2002;51:654-8.
4. Card T, West J, Hubbard R, Logan RF. Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study. Gut 2004;53:251-5.
5. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989;24 (Suppl.170):2-6.
6. Abitbol V, Roux C, Guillemant S, Valleur P, Hautefeuille P, Dougados M, Couturier D, Chaussade S. Bone assessment in patients with ileal pouch-anal anastomosis for inflammatory bowel disease. Br J Surg 1997;84:1551-4.
7. Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO Jr, Engstrom PF, Ezdinli EZ. Horton J. Johnson GJ. Moertel CG. Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Tormey DC. Prognosis effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980; 69:491-7.
8. Harvey RF, Bradshaw JA. A simple index of Crohn's disease activity. Lancet 1980;1:514.
9. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987;317:1625-9.
10. Hadjidakis D, Kokkinakis E, Giannopoulos G, Merakos G, Raptis SA. Bone mineral density of vertebrae, proximal femur and os calcis in normal Greek subjects as assessed by dual-energy X-ray absorptiometry: comparison with other populations. Eur J Clin Invest 1997; 27:219-27.
11. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO Study group. World Health Organ Tech Rep Ser 1994;843:1-129.
12. Martin JP. Tonge KA, Bhonsle U, Jacyna MR, Levi J. Bone mineral density in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 1999; 11:537-41.
13. de Jong DJ, Corstens FH, Mannaerts L, van Rossum LG, Naber AH. Corticosteroid-induced osteoporosis: does it occur in patients with Crohn's disease? Am J Gastroenterol 2002;97:2011-5.
14. Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D. Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol 1998;94:1483-90.
15. Bischoff SC, Herrmann A, Göke M, Manns MP, von zur Muhlen A, Brabant G. Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol 1997; 92:1157-63.
16. Fries W, Giacomin D, Plebani M, Martin A. Effect of experimental colitis on bone metabolism in the rat. Digestion 1994;55:229-33.
17. Lin CL, Moniz C, Chambers TJ, Chow JW. Colitis causes bone loss in rats through suppression of bone formation. Gastroenterol 1996;111:1263-71.
18. Hadjidakis D, Lempert UG, Minne HW, Ziegler R. Bone loss in experimental diabetes. Comparison with the model of inflammation mediated osteopenia. Horm Metab Res 1993;25:77-81.
19. Motley RJ, Crawley EO, Evans C, Rhodes J, Compston JE. Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease. Gut 1988; 29:1332-6.
20. Reffitt DM, Meenan J, Sanderson JD, Jugdaohsingh R, Powell JJ, Thompson RP. Bone density improves with disease remission in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2003;15:1267-73.
21. Staun M, Tjellesen L, Thale M, Schaadt O, Jarnum S. Bone mineral content in patients with Crohn's disease: a longitudinal study in patients with bowel resections. Scand J Gastroenterol 1997;32:226-32.
22. Bjarnason I, Macpherson A, Mackintosh C, Buxton-Thomas M, Forgacs I, Moniz C. Reduced bone density in patients with inflammatory bowel disease. Gut 1997; 40:228-33.
23. Andreassen H, Hylander E, Rix M. Gender, age and body weight are the major predictive factors for bone mineral density in Crohn's disease: a case-control cross-sectional study of 113 patients. Am J Gastroenterol 1999;94:824-8.
24. Ardizzone S, Bollani S, Bettica P, Bevilacqua M, Molteni P, Bianchi Porro G. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis. J Intern Med 2000;247:63-70.